Shandong Buchang Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 15.1% in First Half of 2022

Shandong Buchang Pharmaceuticals Co.,Ltd. (山东步长制药股份有限公司) (603858.SH) reported a net profit of 783.8 million yuan in the first half of 2022, down 15.1% year-on-year.

Meanwhile, the company posted 7.1 billion yuan in revenue, down 3.9% year-on-year.

At the end of the reporting period, it had 24.1 billion yuan in total assets and 9.2 billion yuan in total liabilities, with a liability-to-asset ratio of 38.4%.